Cell and Gene Therapy Catapult Ltd

CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world.

 

Years awarded: 2022, 2025
Region: East of England
Size: 250-999 employees
Sector: Pharmaceuticals and healthcare

CGT website 🡕
IBM UK Ltd
2023 Award

Embedding leadership for strategic growth

Themes: Apprenticeships, Talent pipeline / Career pathwaysUpskilling

Topics: Bespoke training

This independent innovation and technology organisation delivers a 12-week Manager Academy to strengthen frontline leadership through coaching, simulations and psychometric tools. Aligned with organisational goals, it delivers measurable outcomes: reduced turnover, increased promotions and improved stakeholder engagement. With 91% attendance and high satisfaction scores, the programme supports cultural cohesion and internal mobility while also delivering significant recruitment savings.

2023 Award

Creating a future-ready workforce for advanced therapies

Themes: Leadership and Management; Upskilling

Topics: AcademyBespoke trainingCoaching and mentoringIn-house

This independent innovation and technology organisation has evolved its skills and training programmes to tackle critical talent shortages in the cell and gene therapy sector. Since 2022, the organisation has expanded significantly training over 378 apprentices, delivering 8,758 course completions via the Learner Hub and introducing AI and XR learning. There is an 80% retention rate across all apprenticeship programmes and 140 of 160 graduates have remained in the sector.

2022 Award

Tackling skills shortages in the sector

Theme: Apprenticeships

The CGT Catapult introduced an industry-wide apprenticeship programme and learning platform to address skills shortages in the cell and gene therapy sector. Targets of 150 apprenticeship starts by 2022 were exceeded, with 232 apprentices, and a 92% retention rate compared to a national average of 52%. Importantly, learners have emerged as the biggest ambassadors of the programme.

News and case studies featuring Cell and Gene Therapy Catapult:

Pin It on Pinterest

Share This
Princess Royal Training Awards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. For more information see our Privacy Policy.